Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase downregulation-Reference-Cited by-同舟云学术

Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase downregulation

Published:2007-10 Issue:10 Volume:17 Page:841-844
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Mercier Cédric,Raynal Caroline,Dahan Laetitia,Ortiz Adrien,Evrard Alexandre,Dupuis Charlotte,Blesius Aurore,Duluc Muriel,Franceschini Fleur,Giacometti Sarah,Salas Sébastien,Milano Gérard,Favre Roger,Seitz Jean-François,Ciccolini Joseph

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference15 articles.

1. Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics;Gilbert;Clin Cancer Res,2006

2. Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter;Fitzgerald;Hum Genet,2006

3. Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism;Sugiyama;J Clin Oncol,2007

4. Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitro;Kirch;Exp Hematol,1998

5. Structural and functional analysis of the cytidine deaminase gene in patients with acute myeloid leukaemia;Schroder;Br J Haematol,1998

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of a Simple and Reliable HPLC-UV Method for Determining Gemcitabine Levels: Application in Pharmacokinetic Analysis;Medicina;2024-05-25

2. Cytidine deaminase activity increases in the blood of breast cancer patients;Scientific Reports;2022-08-18

3. Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response;Pharmacology & Therapeutics;2022-08

4. Microangiopathy associated with gemcitabine: a drug interaction with nab-paclitaxel? A case series and literature review;European Journal of Clinical Pharmacology;2022-05-04

5. Identification of the key target profiles underlying the drugs of narrow therapeutic index for treating cancer and cardiovascular disease;Computational and Structural Biotechnology Journal;2021